One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Adjuvant Systemic Therapies for Patients with Renal Cell Carcinoma: Choosing Treatment Based on Patient-level Characteristics
PavlosMsaouelabPetrosGrivascTianZhangdef
Urologists, You’ll Never Walk Alone! How Novel Immunotherapy and Modern Imaging May Change the Management of Non–muscle-invasive Bladder Cancer
GianlucaGiannariniaNeerajAgarwalbAndrea B.ApolocAlbertoBrigantidePetrosGrivasfShilpaGuptagAshish M.KamathFrancescoMontorsideMorganRouprêtiAndreaNecchidej
[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature
LauraEvangelistaaTobiasMaurerbHenkvan der PoelcdFilippoAlongiefJolantaKunikowskagRiccardoLaudicellahStefanoFantiijMichael S.Hofmankl
All Prostate-specific Membrane Antigen Peptides Are Equal, but Some Are More Equal than Others
LouiseEmmettaDavid A.PattisonbcMatthew J.Robertscd
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy
Carlo A.BraviaMatteoDroghettibNicolaFossatiaGiorgioGandagliaaNazarenoSuardicElioMazzoneaVitoCucchiaraaSimoneScuderiaFrancescoBarlettaaRiccardoSchiavinabDaniarOsmonovdKlaus-PeterJuenemanndLucaBoeriefR. JeffreyKarneseAlexanderKretschmergAlexanderBuchnergChristianStiefgAndreasHiesterh…AlbertoBrigantia
Managing Discordant Findings Between Multiparametric Magnetic Resonance Imaging and Transrectal Magnetic Resonance Imaging–directed Prostate Biopsy—The Key Role of Magnetic Resonance Imaging–directed Transperineal Biopsy
Anne-SophieBajeotabBertrandCovinaOliverMeyrignaccSarahPericartdRichardAzizacDanielPortalezcPierreGraff-CailleaudeGuillaumePloussardafMathieuRoumiguiéabBernardMalavauda
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy
Shauna R.CampbellaMartin C.TombShreeAgrawalcJason A.EfstathioudJeff M.MichalskieMatthew C.AbramowitzfAlanPollackfDaniel E.SprattgJason W.D.HearnhKevin L.StephansaTianmingGaoiJianboLijRahul D.Tendulkara
Combined Utility of 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Predicting Prostate Biopsy Pathology
Arveen A.KalaparaabcZita E.BallokdShakherRamdaveeRichardO’SullivandAndrewRyanfBadrinathKonetycJeremy P.GrummetabMarkFrydenbergabg
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer
ThomasSteuberaIsabelHeideggerbMonaKafkabMartin A.RoedercFelixChundFelixPreisserdRein-JüriPalisaareJulianHanskeeLarsBudaeusaRalphSchiessfThomasKellergAxelSemjonowhPeterHammereriLukasMankaiThorstenEckejChristianSchwentnerkCarstenOhlmannl
Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy
Timo F.W.SoeterikabHarm H.E.van MelickbLea M.DijksmancHeidiKüsters-VandeveldedSaskiaStompseIvo G.SchootsfDouwe H.BiesmaaJ.A.WitjesgJean-Paul A.van Bastenh
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature
Adam K.AragakiabYuezhouJingabJeanHoffman-CensitsabcWoonyoungChoiabNoah M.HahnabcBruce J.TrockabDavid J.McConkeyabcBurles A.JohnsonIIIa
Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes
Patrick J.HensleyaKelly K.BreeaNathanBrooksaJustinMatulaybRogerLicGraciela M.Nogueras-GonzalezdSupriyaNagarajuaNeemaNavaiaH. BartonGrossmanaColin P.DinneyaAshish M.Kamata
Three-dimensional Magnetic Resonance Imaging–based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy—A Feasibility Study
ChristopherDarrab†FriederikeFinisab†ManuelWiesenfarthcFrancescoGigantideStephanTschirdewahnabUlrichKrafftabClaudiaKeschabDavidBonekampfMichaelForstingbgAxelWetterbgHenningReisbhBoris A.HadaschikabJohannesHauboldbg‡Jan PhilippRadtkeabf‡
Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer
Harry C.BrastianosabcJureMurgicadAdrianaSalcedobMelvin L.K.ChuaaeAliceMengaMichaelFraserabMichaelBrundagecNeil E.FleshnerfTheodorusvan der KwastgRobert G.BristowadhPaul C.BoutrosijklmnoAlejandroBerlinadp
Staging 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer
Charlotte S.VoskuilenaErik J.van Gennepab†Sarah M.H.Einerhanda†ErikVegtcdMaarten L.DonswijkcAnnemarieBruiningeHenk G.van der PoelaSimonHorenblasaKeesHendricksenaBas W.G.van Rhijnaf‡Laura S.Mertensa‡
The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy
AlbertoMartiniaDanieleRaggiaLauraMarandinobFrancescoMontorsiaJeffrey S.RosscdEwan A.GibbeAndreaNecchia
Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor–based Dual Combination Therapy
Niels M.GraaflandabBernadettSzabadoscChandranTanabalandTeeleKuuskeFaizMumtazeRaviBarodeDavidNicoldEkateriniBoletieTomPowlesceJohn B.HaanenfAxelBexabeg
Re: Armando Stabile, Antony Pellegrino, Elio Mazzone, et al. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard. Eur Urol Oncol 2022;5:1–17
KennethChenabJonathanO'BrienacAoifeMcVeyaVeeruKasivisvanathanaDeclan G.Murphyac
